Intracranial Hypertension: When Whooshing Comes With Headaches and Vision Changes

Most pulsatile tinnitus has an identifiable cause, and the article on pulsatile tinnitus covers the range. This is about one of them specifically, because it is the one where the cost of not looking is measured in vision.

The three symptoms

A 2022 review in the Journal of Clinical Neuroscience describes idiopathic intracranial hypertension as raised pressure in the fluid around the brain, showing up as swelling of the optic discs and characteristic findings on imaging, with no identifiable cause behind it. Its primary symptoms, in the review's own order: headache, vision loss, and pulsatile tinnitus.

That ordering is worth sitting with. Pulsatile tinnitus is not an incidental feature of IIH mentioned in a footnote — it is one of the three things the condition presents with, and for some people it is the one that gets them to a doctor.

Why it matters more than the noise does

The tinnitus itself is not dangerous. What it can accompany is.

Untreated IIH damages the optic nerves. The review frames the treatment goals as symptomatic relief and prevention of permanent vision loss, which tells you what is at stake when it is missed. The visual symptoms that go with it are easy to dismiss individually — brief greying or blurring, often on standing or bending, sometimes double vision — and none of them announces itself as an emergency.

This is the concrete reason this site treats pulsatile tinnitus as a reason to be seen rather than a curiosity. Not because whooshing is usually sinister; it usually is not. Because one of the things it can be is a condition where the clock is running on your eyesight.

Who it happens to

The review describes a strong predilection towards women of reproductive age with obesity, and notes the population incidence is rising alongside obesity worldwide. The treatment trial's own group makes the same point sharply: mean age 29, and all but four of the 165 participants were women.

Treat that as a reason to consider the diagnosis rather than a filter that excludes you. It occurs in men, in older people, and at lower weights. A pattern that describes most cases is not a rule that governs all of them.

What the diagnosis actually involves

The finding that matters is papilledema — swelling where the optic nerve enters the eye — which a clinician sees by looking into the eye with the right instrument. Everything else follows from that: imaging to exclude another cause for the pressure, and a lumbar puncture to measure the opening pressure directly.

None of that is something you can assess at home, and no online checklist substitutes for it. What you can do is describe the whole picture rather than the loudest part of it. "I have whooshing in one ear" starts a different appointment from "I have whooshing in one ear, headaches, and my vision greys out when I stand up."

What the trial showed, including where it was thin

The Idiopathic Intracranial Hypertension Treatment Trial is the first randomised controlled trial of its kind in this condition, and it is worth reading precisely rather than as a headline.

It randomised 165 participants with IIH and mild visual loss, all on a low-sodium weight-reduction diet, to the maximum tolerated dose of acetazolamide — up to 4 g a day — or matching placebo, for six months.

• Papilledema improved substantially more on acetazolamide: a treatment effect of −0.70 grades (95% CI −0.99 to −0.41, p < .001).
• Vision-related quality of life improved by 6.35 points more than placebo on the VFQ-25 (95% CI 2.22 to 10.47, p = .003).
• The primary outcome, global visual field loss, improved by 0.71 dB more than placebo — 95% CI 0 to 1.43, p = .050.

That last line is the honest one. The trial's own headline measure landed exactly on the conventional threshold, with a confidence interval whose lower bound touches zero. The secondary findings are cleaner than the primary one. The review that summarises this literature still calls the trial class I evidence for weight loss and acetazolamide, and also says plainly that there are few high-quality prospective studies of treatment and natural history in IIH, and that better research is needed.

For cases that do not respond, or that are severe from the outset, the review lists optic nerve sheath fenestration, CSF diversion, and venous sinus stenting.

That last option is where this condition and a structural one meet. Sigmoid sinus wall abnormalities — a thin or bulging vein wall behind the ear — produce the same whooshing, are found in the same demographic, and are frequently found in the same person. When an operation to rebuild the bone fails to stop the sound, untreated raised pressure is the usual explanation, which is why the two are assessed together rather than in sequence.

What this means for you

• If your tinnitus whooshes in time with your pulse, it is worth an assessment regardless — that article explains why the workup differs from ordinary tinnitus.
• If it comes with headaches or any change in vision, say all three things in the same sentence. The combination is the signal; the parts are not.
• If you are told your eye exam is normal, that is genuinely reassuring for this particular diagnosis, because papilledema is the finding it turns on.
• If IIH is diagnosed, the tinnitus is usually a consequence of the pressure rather than a separate condition to treat. What the evidence supports is treating the pressure.